Acquired Haemophilia A and Kaposi’s Sarcoma in an HIV-Negative, HHV-8-Positive Patient: A Discussion of Mechanism and AetiologyCashin P.a · Lundberg L.G.d · Hagberg H.b · Ejerblad E.c · Karlbom U.a
aSection of Surgery, Department of Surgical Sciences, bSection of Oncology, Department of Oncology, Radiology and Clinical Immunology, and cSection of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, and dSection of Coagulation Disorders, Department of Haematology, Karolinska University Hospital, Stockholm, Sweden
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Acquired haemophilia A (AHA) is a rare bleeding disorder caused by an imbalance in the immune system leading to the production of factor VIII antibodies. In half of the cases, the underlying cause is not known. Clinical History: We report on a patient with AHA and Kaposi’s sarcoma (KS), which is caused by the human herpes virus 8 (HHV-8). The patient presented with appendicitis and developed several severe post-operative haemorrhages. He spent 3 months in intensive care due to long and difficult infections. While recuperating on the ward, the patient developed KS in the lower extremities. He had a positive HHV-8 infection. Discussion/Conclusion: Due to its latency and replication in the lymphoid system, HHV-8 is an ideal candidate for causing an imbalance in the immune system in susceptible patients. Our conclusion is that AHA was caused or prompted by the HHV-8 infection. Since HHV-8 viral infection is often subclinical, viral testing might be an important tool in acquired haemophilia diagnostics even when viral symptoms are absent.
© 2010 S. Karger AG, Basel
- Franchini M, Targher G, Manzato F, Lippi G: Acquired factor VIII inhibitors in oncohematology: a systematic review. Crit Rev Oncol Hematol 2008;66:194–199.
- Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A: Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003;121:21–35.
- Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CR; UK Haemophilia Centre Doctors’ Organisation: Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood 2007;109:1870–1877.
- Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994;266:1865–1869.
- Suchánková A, Stanková M, Roubalová K, Vandasová J, Brůková M: Seroprevalence of HHV 8 antibodies among the general population and HIV positive persons in the Czech Republic. J Clin Virol 2003;28:70–76.
- Hislop AD, Sabbah S: CD8+ T cell immunity to Epstein-Barr virus and Kaposi’s sarcoma-associated herpes virus. Semin Cancer Biol 2008;18:416–422.
- Parsons CH, Adang LA, Overdevest J, O’Connor CM, Taylor JR Jr, Camerini D, Kedes DH: KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J Clin Invest 2006;116:1963–1973.
- Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I, Bugarini R, Parisi SG, Rezza G: Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002;287:1295–1300.
Sarmati L: HHV-8 infection in African children. Herpes 2004;11:50–53.
- Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ: HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis 2008;47:1209–1215.
- Reding MT, Okita DK, Diethelm-Okita BM, Anderson TA, Conti-Fine BM: Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII. J Thromb Haemost 2003;1:1777–1784.
- Pavlova A, Diaz-Lacava A, Zeitler H, Satoguina J, Niemann B, Krause M, Scharrer I, Hoerauf A, Wienker T, Oldenburg J: Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls. Haemophilia 2008;14:355–360.
- Gilles JG, Saint-Remy JM: Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. J Clin Invest 1994;94:1496–1505.
- Guilbert B, Dighiero G, Avrameas S: Naturally occurring antibodies against nine common antigens in human sera. J Immunol 1982;128:2779–2787.
- Marietta M, Pozzi S, Luppi M, Bertesi M, Cappi C, Morselli M, Torelli G: Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman’s disease: a case report. Eur J Haematol 2003;70:181–182.
- Frizzera G, Peterson BA, Bayrd ED, Goldman A: A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202–1216.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.